Dipeptidyl peptidase - PDFSEARCH.IO - Document Search Engine

Dipeptidyl peptidase
Results: 124

#	Item
41	Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2012 to year end: Jun[removed]Section 85 Only Year ending Jun 2012 Rank Drug Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:26 Dipeptidyl peptidase-4 inhibitors Amides Organofluorides Recombinant proteins Sitagliptin Metformin Vildagliptin Exenatide Insulin glargine Chemistry Anti-diabetic drugs Organic chemistry
42	Table 8(b):Significant Drugs (incl Drs Bag)-Sorted by highest volume change, year end: Jun 2012 to year end: Jun[removed]Section 85 Only Year ending Jun 2012 Rank Drug Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:26 Organofluorides Amides Dipeptidyl peptidase-4 inhibitors Organochlorides Ezetimibe Metformin Sitagliptin Vildagliptin Amlodipine Chemistry Organic chemistry Anti-diabetic drugs
43	PDF Document Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-09 02:50:09 Medicine Anti-diabetic drugs Thiazolidinediones Amides Dipeptidyl peptidase-4 inhibitors Metformin Diabetes management Vildagliptin Saxagliptin Chemistry Organic chemistry Diabetes
44	DOCX Document Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-09 02:50:09 Endocrine system Diabetes Dipeptidyl peptidase-4 inhibitors Amides Eli Lilly and Company Anti-diabetic medication Metformin Vildagliptin Exenatide Chemistry Organic chemistry Anti-diabetic drugs
45	Type 2 Diabetes review – ToR 4 COMPARATIVE SAFETY AND EFFECTIVENESS OF TYPE 2 DIABETES MEDICINES FINAL REPORT Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-09 02:50:10 Diabetes Anti-diabetic drugs Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Design of experiments Anti-diabetic medication Diabetes management Exenatide Metformin Chemistry Medicine Organic chemistry
46	R&D Snapshot Manipulating Incretin Secretion from the Gastrointestinal Tract to Regulate Feed Intake in Pigs Investigators: Associate Professor Brian Leury, The University of Melbourne Purpose: Add to Reading List Source URL: australianpork.com.au Language: English - Date: 2015-01-08 20:09:52 Anti-diabetic drugs Medicine Endocrinology Dipeptidyl peptidase-4 inhibitors Intestinal hormones Sitagliptin Incretin Gastrointestinal hormone Hormone Biology Peptide hormones Endocrine system
47	Review of Diabetes Management Terms of Reference 3 Final Report May 2014 Newcastle Evaluation Group (NEG) Discipline of Clinical Pharmacology Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-09 02:50:09 Endocrine system Dipeptidyl peptidase-4 inhibitors Diabetes Peptide hormones Eli Lilly and Company Anti-diabetic medication Exenatide Metformin Pioglitazone Chemistry Organic chemistry Anti-diabetic drugs
48	THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck Add to Reading List Source URL: media.mmm-online.com Language: English - Date: 2013-05-21 21:35:48 Pyridines Benzamides Bristol-Myers Squibb Organofluorides Dipeptidyl peptidase-4 inhibitor Tofacitinib Pfizer GlaxoSmithKline Axitinib Chemistry Organic chemistry Carbamates
49	D I A B E T E S T R E A T M E N T S DPP-4 Inhibitors Impact on glycemic control and cardiovascular risk factors Add to Reading List Source URL: care.diabetesjournals.org Language: English - Date: 2011-06-16 18:08:48 Dipeptidyl peptidase-4 inhibitors Endocrine system Amides Diabetes Peptide hormones Sitagliptin Saxagliptin Anti-diabetic medication Vildagliptin Chemistry Anti-diabetic drugs Organic chemistry
50	THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than Add to Reading List Source URL: media.mmm-online.com Language: English - Date: 2013-05-21 21:41:53 Dipeptidyl peptidase-4 inhibitor Immunology Infliximab Rosiglitazone Diabetes mellitus type 1 Lixisenatide GlaxoSmithKline Medicine Schering-Plough Pharmacology

UPDATE